Skip to content

Clinical trials

Non-ST Elevated Myocardial Infarction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-ST Elevated Myocardial Infarction Country / region: United States Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20062
20071
20081
20093
20111
20131
20141
20153
20162
20171
20184
20193
20205
20211
20224
20234
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting7
Terminated5
Unknown status4
Not yet recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Abiomed Inc.2
AstraZeneca2
Henry Ford Health System2
Massachusetts General Hospital2
Mayo Clinic2
Population Health Research Institute2
SB Technology, Inc.2
Amgen1
Baim Institute for Clinical Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-ST Elevated Myocardial Infarction45
ST Elevation Myocardial Infarction21
Acute Coronary Syndrome20
Myocardial Infarction14
Angina, Unstable12
Coronary Artery Disease11
Angina, Stable7
Cardiovascular Diseases4
Chest Pain4
Emergencies2

Trials

Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.